Department of Medicine 1 – Gastroenterology, Pneumology and Endocrinology


close-button

Project Types

Third Party Funds Group - Overall project
Third Party Funds Group - Sub project
Third party funded individual grant
Internally funded project
FAU own research funding: EFI / IZKF / EAM ...
Non-FAU Project

Status

Project year

From
To
A102: Mechanical properties of innate immune cells: functional relevance and therapeutic implications in colitis July 1, 2023 - Dec. 31, 2025 J101: AI-based support for histopathology evaluation of autoinflammatory and malignant GI diseases Jan. 1, 2023 - Dec. 31, 2025 Intestinal epithelial cell death as modulator of intestinal dysbiosis, systemic autoimmunity and the onset of arthritis (FOR 2886 A2) FOR 2886: PANDORA - Pathways triggering AutoimmuNity and Defining Onset of early Rheumatoid Arthritis July 1, 2018 - Dec. 31, 2025 IZKF-S2 Tame the Flame (M3): Interplay of cell trafficking and mechanics as a pathomechanism in immune-mediated inflammation “TAME THE FLAME” Jan. 1, 2024 - Dec. 31, 2025 D037: ACLY as a therapeutic target to promote T cell-driven antitumor immune response in IBD-associated colon cancer April 1, 2023 - Sept. 30, 2025 A101: Atypical, anti-viral IgG4 antibody responses after SARS-CoV-2 mRNA vaccination April 1, 2023 - Sept. 30, 2025 J099: The role of reactive carbonyls in metabolic-dysfunction associated neuropathic pain and chronic liver disease Oct. 1, 2022 - Sept. 30, 2025 IZKF-N5 Organ crosstalk in IMIDs(321/M1: Role of extracellular vesicles as biological shuttle system for inter-kingdom communication and organ crosstalk July 1, 2021 - March 31, 2025 P142: Investigation of stromal IL36R signaling during intestinal inflammation and fibrosis Nov. 16, 2023 - Nov. 15, 2024 J096: Role of amyloidogenic B-secretases as regulators of the tumor-stroma crosstalk in colorectal cancer Oct. 1, 2021 - Sept. 30, 2024
1 2 3 4 5 6 ... 8